dc.creator | Jevtić, Ivana | |
dc.creator | Penjišević, Jelena | |
dc.creator | Kostić-Rajačić, Slađana | |
dc.date.accessioned | 2023-02-27T13:41:05Z | |
dc.date.available | 2023-02-27T13:41:05Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://cer.ihtm.bg.ac.rs/handle/123456789/5837 | |
dc.description.abstract | Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by deterioration of
cognitive skills and it is the most abundant form of dementia according to the World Health Organization
(WHO).1 Tacrine belongs to a class of acetylcholinesterase inhibitors (AChEIs) and it was formerly used in the
treatment of AD symptoms. Albeit no longer in clinical use due to its hepatotoxicity, tacrine ring system is
extensively investigated as pharmacophore in novel AChEIs, many of which showed improved pharmacological
profile in the preclinical studies.2 Here we present optimized synthetic pathway and pharmacological evaluation
of three novel tacrine derivatives (5, 6 and 7), possessing functionalized piperidine connected with tacrine via
five methylene groups alkyl chain | sr |
dc.language.iso | en | sr |
dc.publisher | The Société de Chimie Thérapeutique (SCT) / French Medicinal Chemistry Society | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200026/RS// | sr |
dc.rights | restrictedAccess | sr |
dc.source | Book of abstracts - 56th International conference on medicinal chemistry, RICT 2021, "Interfacing chemical biology and drug discovery", July 7-9, 2021, virtual event | sr |
dc.subject | Alzheimer's disease | sr |
dc.subject | Tacrine | sr |
dc.subject | acetylcholinesterase inhibitors | sr |
dc.title | Synthesis and pharmacological evaluation of novel tacrine derivatives as potential acetylcholinesterase inhibitors | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.citation.spage | 119 | |
dc.citation.epage | 119 | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_cer_5837 | |
dc.type.version | publishedVersion | sr |